251 related articles for article (PubMed ID: 30243803)
1. LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.
Game F; Jeffcoate W; Tarnow L; Jacobsen JL; Whitham DJ; Harrison EF; Ellender SJ; Fitzsimmons D; Löndahl M;
Lancet Diabetes Endocrinol; 2018 Nov; 6(11):870-878. PubMed ID: 30243803
[TBL] [Abstract][Full Text] [Related]
2. The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.
Game F; Jeffcoate W; Tarnow L; Day F; Fitzsimmons D; Jacobsen J
Trials; 2017 Oct; 18(1):469. PubMed ID: 29017535
[TBL] [Abstract][Full Text] [Related]
3. Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study.
Löndahl M; Tarnow L; Karlsmark T; Lundquist R; Nielsen AM; Michelsen M; Nilsson A; Zakrzewski M; Jörgensen B
J Wound Care; 2015 Apr; 24(4):172-4, 176-8. PubMed ID: 25853474
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial.
Jeffcoate W; Game F; Turtle-Savage V; Musgrove A; Price P; Tan W; Bradshaw L; Montgomery A; Fitzsimmons D; Farr A; Winfield T; Phillips C
Health Technol Assess; 2017 May; 21(34):1-92. PubMed ID: 28644115
[TBL] [Abstract][Full Text] [Related]
5. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.
Edmonds M; Lázaro-Martínez JL; Alfayate-García JM; Martini J; Petit JM; Rayman G; Lobmann R; Uccioli L; Sauvadet A; Bohbot S; Kerihuel JC; Piaggesi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):186-196. PubMed ID: 29275068
[TBL] [Abstract][Full Text] [Related]
6. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
7. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
[TBL] [Abstract][Full Text] [Related]
8. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers.
Lafontaine N; Jolley J; Kyi M; King S; Iacobaccio L; Staunton E; Wilson B; Seymour C; Rogasch S; Wraight P
Diabetologia; 2023 Apr; 66(4):768-776. PubMed ID: 36629877
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(5):1-142. PubMed ID: 28572866
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes.
Jeffcoate WJ; Price PE; Phillips CJ; Game FL; Mudge E; Davies S; Amery CM; Edmonds ME; Gibby OM; Johnson AB; Jones GR; Masson E; Patmore JE; Price D; Rayman G; Harding KG
Health Technol Assess; 2009 Nov; 13(54):1-86, iii-iv. PubMed ID: 19922726
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.
Edmonds ME; Bodansky HJ; Boulton AJM; Chadwick PJ; Dang CN; D'Costa R; Johnston A; Kennon B; Leese G; Rajbhandari SM; Serena TE; Young MJ; Stewart JE; Tucker AT; Carter MJ
Wound Repair Regen; 2018 Mar; 26(2):228-237. PubMed ID: 29617058
[TBL] [Abstract][Full Text] [Related]
13. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
[TBL] [Abstract][Full Text] [Related]
14. Management of hard-to-heal leg ulcers with an acid-oxidising solution versus standard of care: the MACAN study.
Strohal R; Mittlböck M; Müller W; Hämmerle G
J Wound Care; 2021 Sep; 30(9):694-704. PubMed ID: 34554831
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.
Stratmann B; Costea TC; Nolte C; Hiller J; Schmidt J; Reindel J; Masur K; Motz W; Timm J; Kerner W; Tschoepe D
JAMA Netw Open; 2020 Jul; 3(7):e2010411. PubMed ID: 32672829
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
17. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
18. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
[TBL] [Abstract][Full Text] [Related]
19. Autologous platelet-rich plasma for treating chronic wounds.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Expósito JA; Bolíbar I; Rodríguez L; Garcia J
Cochrane Database Syst Rev; 2012 Oct; 10():CD006899. PubMed ID: 23076929
[TBL] [Abstract][Full Text] [Related]
20. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalised tissue: pilot study.
Eliasson B; Fagerdahl AM; Jönsson A; Apelqvist J
J Wound Care; 2021 Jun; 30(6):455-464. PubMed ID: 34121441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
